STUDYING NATURE, RISK STRATIFICATION AND DRUGS IMPACT ON ARRHYTHMOGENIC RIGHT CARDIOMYOPATHY

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a form of cardiomyopathy that mostly occurs in young seemingly healthy individuals and athletes, causing sudden cardiac death and ventricular tachyarrhythmias [1]. The illness is described by limited or diffuse decay of prevalently right ventricular myocardium with resulting substitution by greasy and stringy tissue [2,3]. These underlying irregularities are principally situated in the surge plot, summit, and sub tricuspid zone of the privilege ventricular free divider [4].